Simple Science

Cutting edge science explained simply

# Health Sciences# Gastroenterology

Genetic Insights into Irritable Bowel Syndrome Symptoms

Research links genetic variations to IBS symptoms and quality of life.

― 6 min read


Genetics of IBS SymptomsGenetics of IBS SymptomsRevealedissues.IBS-related pain and mental healthStudy uncovers genetic links to
Table of Contents

Irritable Bowel Syndrome, commonly known as IBS, is a health issue that affects how the gut and brain communicate. People with this condition often experience changes in their bowel movements and ongoing stomach pain. Along with these main symptoms, individuals with IBS may also face other problems like back pain, headaches, aching joints, tiredness, and trouble sleeping. Studies show that those with IBS are more likely to have other conditions, like fibromyalgia and migraines, which are linked to pain. There is also a higher chance for these individuals to suffer from anxiety or depression compared to people who do not have IBS.

The reasons behind IBS symptoms are complex and still being researched. Some studies have focused on factors like problems with serotonin levels, changes in bile production, how well the gut can absorb substances, immune system activity, the balance of bacteria in the gut, and changes in how the brain functions. Genetics also plays a significant role in IBS. Research has looked at how certain genes may influence both gut symptoms and other related discomforts, but identifying specific genetic variations related to IBS has been challenging.

The Role of Brain-derived Neurotrophic Factor (BDNF)

One important element in understanding IBS is a protein called brain-derived neurotrophic factor (BDNF). This protein is involved in how our nerve cells develop and function. BDNF works through a receptor known as TrkB, which is influenced by specific genes. Different forms of this receptor can either promote or limit BDNF's effects. In animal studies and human cases, one specific form of the TrkB receptor has been connected to higher chances of experiencing pain and mood disorders. Understanding how these receptors affect IBS can shed light on the condition and its symptoms.

Genetic variations, especially in the TrkB gene, may play a role in how symptoms appear in people with IBS. One key aspect of this gene involves a section called the 3’ untranslated region (3'UTR), which can influence how well the gene functions. Research suggests that variations in this area may have a significant impact on how symptoms manifest in IBS patients.

In this study, we examined how particular genetic markers, known as Single Nucleotide Polymorphisms (SNPS), in both BDNF and TrkB genes, relate to the symptoms experienced by people with IBS. We focused on 14 specific SNPs, including one known to affect BDNF levels. Our goal was to see how these genetic variations connect to three symptom areas: stomach pain and other bodily aches, psychological issues, and overall quality of life.

Study Participants

Our research involved data from five independent studies carried out in the Pacific Northwest region of the United States. Three of these studies focused on better understanding IBS mechanisms and included women with IBS and healthy women as a control group. The other two studies were clinical trials examining self-management strategies for both men and women with IBS. Only the early data from the intervention studies were used for our analysis.

Participants were recruited through local medical practices and community ads. To qualify for the IBS group, people had to have a confirmed diagnosis for at least six months. The control group, known as healthy controls (HCs), was made up of individuals who did not have significant health issues. Blood samples were collected from all participants for genetic testing.

Study Measures

We collected various types of information from participants. A demographic survey gathered details about their age, race, gender, marital status, education, and income. To track symptoms over time, participants used a daily diary to record how severe their symptoms were within the last day, rating them from "not present" to "very severe." Symptoms included abdominal pain, headaches, joint and muscle pain, and psychological symptoms like anxiety and sadness.

To assess Psychological Distress, we used a standardized tool known as the Brief Symptom Inventory, which looks at anxiety and depression levels. For those with IBS, we evaluated their quality of life related to the condition using a specific questionnaire. This assessed how IBS symptoms impacted their daily life over the past month.

Genetic Testing

We extracted DNA from the blood samples for genetic analysis. Using specific testing kits, we prepared the DNA samples and analyzed them to identify genetic variations related to IBS.

We focused on 14 SNPs, checking their presence in our participants. Some SNPs did not show up in all studies, so we only kept those that had sufficient data for analysis. After quality checks, 11 SNPs were included in our final assessment.

Data Analysis

After gathering data from all studies, we compared the demographic characteristics of IBS patients with healthy controls. We used statistical methods to evaluate the associations between the SNPs and IBS status while considering factors like age, sex, and study design.

We looked at how these SNPs relate to various symptoms, analyzing whether the number of certain alleles (gene variants) affects symptom severity. We also validated our findings using data from larger databases.

Symptoms and Genetic Associations

In our analysis, we found that individuals with IBS suffer more from both somatic pain and psychological issues compared to healthy controls. They reported higher levels of abdominal pain, headaches, and other bodily pains, along with more anxiety and depression.

When examining genetic factors, we identified a significant link between one SNP, rs2013566, and an increased likelihood of experiencing IBS. We also found that this SNP was associated with various somatic symptoms, with certain genotypes connected to specific symptom patterns.

For example, those with a particular genotype at rs2013566 reported more issues related to back pain and headaches, highlighting its potential role in how IBS symptoms manifest. Additionally, others SNPs were linked to muscle pain and overall quality of life among IBS patients.

External validation using other databases further supported some of our findings, particularly regarding the association between rs2013566 and headaches. Overall, these results underscore the complex nature of genetic influences on IBS symptoms.

Conclusions

Our research highlights the role of genetic factors in understanding irritable bowel syndrome. We found clear associations between specific genetic variations in BDNF and TrkB genes and various symptoms experienced by individuals with IBS. This knowledge could help inform future treatments or interventions for managing the condition, potentially leading to personalized approaches based on genetic information.

While our study provides valuable insights into the genetic aspects of IBS, it also points out the need for more extensive research to explore other genetic variants and their potential contributions to this complex condition. Understanding the interplay between genetics, psychological factors, and environmental influences on IBS could help improve management and quality of life for those affected.

In summary, the genetic variations identified in our study offer a glimpse into the complex web of factors affecting irritable bowel syndrome, emphasizing the need for further exploration into how these elements interact and influence symptom severity.

Original Source

Title: Genetic Variations in TrkB.T1 Isoform and Their Association with Somatic and Psychological Symptoms in Individuals with IBS

Abstract: Irritable bowel syndrome (IBS), a disorder of gut-brain interaction, is often comorbid with somatic pain and psychological disorders. Dysregulated signaling of brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), has been implicated in somatic-psychological symptoms in individuals with IBS. Thus, we investigated the association of 10 single nucleotide polymorphisms (SNPs) in the regulatory 3 untranslated region (UTR) of NTRK2 (TrkB) kinase domain-deficient truncated isoform (TrkB.T1) and the BDNF Val66Met SNP with somatic and psychological symptoms and quality of life in a U.S. cohort (IBS n=464; healthy controls n=156). We found that the homozygous recessive genotype (G/G) of rs2013566 in individuals with IBS is associated with worsened somatic symptoms, including headache, back pain, joint pain, muscle pain, and somatization as well as diminished sleep quality, energy level and overall quality of life. Validation using U.K. BioBank (UKBB) data confirmed the association of rs2013566 with increased likelihood of headache. Several SNPs (rs1627784, rs1624327, rs1147198) showed significant associations with muscle pain in our U.S. cohort. Notably, these SNPs are predominantly located in H3K4Me1-enriched regions, suggesting their enhancer and/or transcription regulation potential. Together, our findings suggest that genetic variation within the 3UTR region of the TrkB.T1 isoform may contribute to comorbid conditions in individuals with IBS, resulting in a spectrum of somatic and psychological symptoms that may influence their quality of life. These findings advance our understanding of the genetic interaction between BDNF/TrkB pathways and somatic-psychological symptoms in IBS, highlighting the importance of further exploring this interaction for potential clinical applications.

Authors: Susan G Dorsey, H. Hong, E. Mocci, K. Kamp, S. Zhu, K. C. Cain, R. L. Burr, J. A. Perry, M. M. Heitkemper, K. Weaver-Toedtman

Last Update: 2023-09-14 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2023.09.14.23295434

Source PDF: https://www.medrxiv.org/content/10.1101/2023.09.14.23295434.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles